{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:53:47Z","timestamp":1791176027191,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.cgh.2015.07.035","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T15:37:13Z","timestamp":1438443433000},"page":"156-164.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection"],"prefix":"10.1016","volume":"14","author":[{"given":"Lynn","family":"Gerber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Estep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey","family":"Escheik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2015.07.035_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","article-title":"Fatigue in patients with chronic hepatitis C","volume":"9","author":"Poynard","year":"2002","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2015.07.035_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1310\/hct0805-320","article-title":"Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research","volume":"8","author":"Marcellin","year":"2007","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.cgh.2015.07.035_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2012.06.030","article-title":"Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study","volume":"57","author":"Sarkar","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2015.07.035_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3999(00)00155-0","article-title":"Depression, fatigue, and functional disability in patients with chronic hepatitis C","volume":"49","author":"Dwight","year":"2000","journal-title":"J\u00a0Psychosom Res"},{"key":"10.1016\/j.cgh.2015.07.035_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2702.2003.00709.x","article-title":"The experience of fatigue for people living with hepatitis C","volume":"12","author":"Glacken","year":"2003","journal-title":"J\u00a0Clin Nurs"},{"key":"10.1016\/j.cgh.2015.07.035_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1155\/2006\/624832","article-title":"Fatigue in liver disease: pathophysiology and clinical management","volume":"20","author":"Swain","year":"2006","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.07.035_bib7","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s10620-006-9708-x","article-title":"Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection","volume":"52","author":"Kallman","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.07.035_bib8","series-title":"ACSM\u2019s advanced exercise physiology","first-page":"178","article-title":"The muscular system: fatigue processes","author":"Fitts","year":"2006"},{"key":"10.1016\/j.cgh.2015.07.035_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pmrj.2010.03.028","article-title":"What is fatigue? pathological and nonpathological fatigue","volume":"2","author":"Jason","year":"2010","journal-title":"PM&R"},{"key":"10.1016\/j.cgh.2015.07.035_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1152\/jappl.1992.72.5.1631","article-title":"Neurobiology of muscle fatigue","volume":"72","author":"Enoka","year":"1992","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.cgh.2015.07.035_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4899-1016-5_22","article-title":"Central fatigue: critical issues, quantification and practical implications","volume":"384","author":"Gandevia","year":"1995","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.cgh.2015.07.035_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pmrj.2010.03.027","article-title":"Central fatigue: issues related to cognition, mood and behavior, and psychiatric diagnoses","volume":"2","author":"Leavitt","year":"2010","journal-title":"PM&R"},{"key":"10.1016\/j.cgh.2015.07.035_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.26229","article-title":"Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C","volume":"58","author":"Kraus","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.07.035_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jvh.12365","article-title":"Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared\u00a0with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 an","volume":"22","author":"Scott","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2015.07.035_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.20659","article-title":"Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment","volume":"41","author":"Spiegel","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.07.035_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.45.2.295","article-title":"Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease","volume":"45","author":"Younossi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.07.035_bib17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cgh.2015.07.035_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","article-title":"Measuring fatigue and other anemia related symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System","volume":"13","author":"Yellen","year":"1997","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.cgh.2015.07.035_bib19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection","volume":"370","author":"Afdahl","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.07.035_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): II\u2014psychometric and clinical tests of validity in measuring physical and mental health constructs","volume":"31","author":"McHorney","year":"1993","journal-title":"Med Care"},{"key":"10.1016\/j.cgh.2015.07.035_bib21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/hep.27724","article-title":"Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: results from the ION-1, -2, and -3 clinical trials","volume":"61","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.07.035_bib22","first-page":"93A","article-title":"Two types of fatigue in subjects with chronic liver disease can be distinguished through correlations with physical activity and mental symptoms","volume":"60","author":"Weinstein","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2015.07.035_bib23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.10507","article-title":"Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center","volume":"94","author":"Hwang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2015.07.035_bib24","article-title":"Ribavirin restores IFN\u03b1 responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes","author":"Testoni","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.07.035_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/08923973.2014.971962","article-title":"Ribavirin shows immunomodulatory effects on activated microglia","volume":"36","author":"Savic","year":"2014","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.cgh.2015.07.035_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/35006097","article-title":"Control of Th2 polarization by chemokine monocyte chemoattractant protein-1","volume":"404","author":"Gu","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cgh.2015.07.035_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11136-014-0804-7","article-title":"Contribution of symptom clusters to multiple sclerosis consequences","volume":"24","author":"Shahrbanian","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cgh.2015.07.035_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2010.01.017","article-title":"Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C","volume":"221","author":"Hilsabeck","year":"2010","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.cgh.2015.07.035_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10620-007-9896-z","article-title":"Cognitive dysfunction in chronic hepatitis C: a review","volume":"53","author":"Perry","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2015.07.035_bib30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1017\/S0033291711002868","article-title":"Molecular signatures of peripheral blood mononuclear cells during chronic interferon-\u03b1 treatment: relationship with depression and fatigue","volume":"42","author":"Felger","year":"2012","journal-title":"Psychol Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515010502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515010502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:19:29Z","timestamp":1761542369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356515010502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1542356515010502"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2015.07.035","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Viral Eradication With Ledipasvir and Sofosbuvir, With or Without Ribavirin, on Measures of Fatigue in Patients With Chronic Hepatitis C Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2015.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}